1Mcclure R, Mai M, Lasho T. Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders[J]. Leukemia, 2006, 20(1) :168 -171.
2Lehot JJ ,Was B,Denddeu I., etal. Oxygenator thrombo- sis without heparin resistance in polycythemia vera[J]. Ann Fr Anesth Reanim, 2012,31 Suppl 1 : S14- 17.
3Ural AU,Cetin T, Aveu F. Antithrombotic challenges af- ter coronary artery surgery in patients with polyeytemia vera[J]. Card Surg,2008,23(4):410.
